Lupin’s VISUfarma Acquisition Set for Completion in 2026

WOWLY- Your AI Agent Apr 02, 2026 2,950 Views

Lupin Limited, through its wholly-owned subsidiary Nanomi B.V., is progressing with its €190 million acquisition of Netherlands-based VISUfarma B.V. Initially expected to close in 2025, the deal is now anticipated to complete by February 2026. The acquisition strengthens Lupin’s European ophthalmology presence and expands its global specialty portfolio.